Nurix Therapeutics (NRIX) Return on Equity [ROE] (2020 - 2026)
Nurix Therapeutics (NRIX) posted Return on Equity [ROE] of 43.02% for fiscal Q3 2026 (quarter ended Aug 31, 2026), up 102.74 percentage points from -59.71% a year earlier and up 120.29 percentage points from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025 (ended Nov 30, 2025), Nurix Therapeutics' Return on Equity [ROE] came in at -49.63%, up 3.59 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of -12.44 percentage points (FY2020 to FY2025).
- In prior fiscal years, Nurix Therapeutics' Return on Equity [ROE] was -53.22% in FY2024 (+3.88 pp), -57.10% in FY2023 (-1.26 pp), -55.84% in FY2022 (-18.79 pp) and -37.05% in FY2021 (+0.14 pp).
- The fiscal Q3 2026 figure stands as the highest quarterly Return on Equity [ROE] in data going back to fiscal Q3 2020.
- On a year-over-year basis, Return on Equity [ROE] increased in four of the last eight quarters, with an average year-over-year change of +12.88 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was fiscal Q3 2026, with a gain of 102.74 percentage points; the weakest was fiscal Q2 2026, with a drop of 32.61 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior fiscal quarters was -77.26% (Q2 2026), -57.91% (Q1 2026) and -58.05% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.88 Bn | 1,136.47 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 648.57 Bn | 568.43 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 504.09 Bn | 477.21 Bn | 12.70 Bn | - |
| 4 | Merck | 366.15 Bn | 320.53 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 303.24 Bn | 267.23 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 268.72 Bn | 242.40 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 242.67 Bn | 198.06 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 195.02 Bn | 169.22 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 172.77 Bn | 119.41 Bn | 10.94 Bn | 4.97% |
| 10 | Nurix Therapeutics | 2.84 Bn | 217.17 Mn | - | 43.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 43.02% |
| May 31, 2026 | -77.27% |
| Feb 28, 2026 | -57.92% |
| Nov 30, 2025 | -58.06% |
| Aug 31, 2025 | -59.71% |
| May 31, 2025 | -44.66% |
| Feb 28, 2025 | -41.35% |
| Nov 30, 2024 | -42.83% |
| Aug 31, 2024 | -47.35% |
| May 31, 2024 | -61.18% |
| Feb 29, 2024 | -78.39% |
| Nov 30, 2023 | -66.29% |
| Aug 31, 2023 | -60.24% |
| May 31, 2023 | -58.97% |
| Feb 28, 2023 | -61.81% |
| Nov 30, 2022 | -55.82% |
| Aug 31, 2022 | -56.24% |
| May 31, 2022 | -53.94% |
| Feb 28, 2022 | -41.79% |
| Nov 30, 2021 | -32.66% |
API Access
Nurix Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();